Patents by Inventor Vivianne Malmstström

Vivianne Malmstström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
    Patent number: 12180265
    Abstract: A pharmaceutical composition comprises (a) a peptide of 8 to 20 amino acids comprising at least one citrulline residue and 13, 14 or 15 consecutive amino acids residues with a sequence present in SEQ ID NO 22 or a complex of said peptide and a human recombinant MHC class II protein, and (b) an immunologic adjuvant.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: December 31, 2024
    Assignee: Curara AB
    Inventors: Lars Klareskog, Vivianne Malmstström
  • NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT
    Publication number: 20200277357
    Abstract: A pharmaceutical composition comprises (a) a peptide of between 8 and 20 amino acids comprising at least 8 consecutive amino acids residues with a sequence present in SEQ ID NO 22 or a complex of said peptide and a human recombinant MHC class II protein and (b) an immunologic adjuvant.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 3, 2020
    Inventors: Lars Klareskog, Vivianne Malmstström
  • NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT
    Publication number: 20150218546
    Abstract: It is provided novel peptides from human alpha-enolase, collagen type II and vimentin that bind to types of MHC class II that is associated with rheumatoid arthritis. There is also provided novel therapies and methods for diagnosis of rheumatoid arthritis.
    Type: Application
    Filed: April 5, 2012
    Publication date: August 6, 2015
    Inventors: Lars Klareskog, Vivianne Malmstström, Rikard Holmdahl